DK0606452T3 - Vektorvacciner fra rekombinant katteherpesvirus - Google Patents

Vektorvacciner fra rekombinant katteherpesvirus

Info

Publication number
DK0606452T3
DK0606452T3 DK93917639T DK93917639T DK0606452T3 DK 0606452 T3 DK0606452 T3 DK 0606452T3 DK 93917639 T DK93917639 T DK 93917639T DK 93917639 T DK93917639 T DK 93917639T DK 0606452 T3 DK0606452 T3 DK 0606452T3
Authority
DK
Denmark
Prior art keywords
fhv
herpes virus
vector vaccines
recombinant
mutant
Prior art date
Application number
DK93917639T
Other languages
Danish (da)
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Martha Jacoba Willemse
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0606452(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0606452T3 publication Critical patent/DK0606452T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
DK93917639T 1992-07-30 1993-07-23 Vektorvacciner fra rekombinant katteherpesvirus DK0606452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202365 1992-07-30
PCT/EP1993/001971 WO1994003621A1 (fr) 1992-07-30 1993-07-23 Vaccins vecteurs d'herpesvirus felin recombine

Publications (1)

Publication Number Publication Date
DK0606452T3 true DK0606452T3 (da) 2003-03-17

Family

ID=8210815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917639T DK0606452T3 (da) 1992-07-30 1993-07-23 Vektorvacciner fra rekombinant katteherpesvirus

Country Status (10)

Country Link
US (1) US6521236B1 (fr)
EP (1) EP0606452B1 (fr)
JP (1) JP3529134B2 (fr)
AT (1) ATE227775T1 (fr)
AU (1) AU4702293A (fr)
DE (1) DE69332480T2 (fr)
DK (1) DK0606452T3 (fr)
ES (1) ES2187508T3 (fr)
PT (1) PT606452E (fr)
WO (1) WO1994003621A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000172A1 (fr) * 1993-06-24 1995-01-05 Michigan State University Vaccin recombine a deletion contre l'herpesvirus felin et son procede de preparation
US5833993A (en) * 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
AU761755B2 (en) * 1998-05-01 2003-06-12 Schering-Plough Ltd Recombinant virus expressing foreign DNA encoding feline CD80, feline CTLA-4 or feline CD86 and uses thereof
JP2002112770A (ja) * 2000-10-05 2002-04-16 Kyoritsu Seiyaku Kk 新規組換えネコヘルペスウイルス１型およびこれを用いた多価ワクチン
WO2009051823A2 (fr) * 2007-10-18 2009-04-23 Michigan State University Chromosome bactérien artificiel contenant le génome du virus de l'herpès félin de type 1 et ses utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591145B2 (en) * 1985-07-29 1989-11-30 Pharmacia & Upjohn Company Virus vaccine with deletion of an antigen of the wild-type virus
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
WO1987004463A1 (fr) * 1986-01-27 1987-07-30 Syntro Corporation Virus herpetiques attenues, virus herpetiques comprenant de l'adn etranger contenant une sequence d'acide amine et vaccin les contenant
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
WO1995000172A1 (fr) 1993-06-24 1995-01-05 Michigan State University Vaccin recombine a deletion contre l'herpesvirus felin et son procede de preparation

Also Published As

Publication number Publication date
JP3529134B2 (ja) 2004-05-24
ES2187508T3 (es) 2003-06-16
EP0606452B1 (fr) 2002-11-13
JPH06511392A (ja) 1994-12-22
ATE227775T1 (de) 2002-11-15
EP0606452A1 (fr) 1994-07-20
AU4702293A (en) 1994-03-03
WO1994003621A1 (fr) 1994-02-17
PT606452E (pt) 2003-03-31
DE69332480T2 (de) 2003-07-17
DE69332480D1 (de) 2002-12-19
US6521236B1 (en) 2003-02-18

Similar Documents

Publication Publication Date Title
CA2031164A1 (fr) Herpesvirus recombinant de dindons et vaccins de vecteur vivant qui en sont derives
DE3786824D1 (de) Rekombinante herpes simplex-viren, vakzine und verfahren.
OA09777A (en) "Viral defective vaccine produced by transcomplementing cell line"
DK0776361T3 (da) Rekombinant herpesvirus fra kalkuner og anvendelser deraf
DK0606452T3 (da) Vektorvacciner fra rekombinant katteherpesvirus
ATE226257T1 (de) Rekombinanter katzen-herpesvirus-impfstoff
PT1307565E (pt) Vacina contra o vírus da doença de marek (mdv) e o vírus da varicela zoster
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
AU1624292A (en) Recombinant vaccine against marek's disease
ATE180278T1 (de) Auf dem gb-protein des marek's disease virus (mdv) basierende, rekombinante impfstoffe
CA2196416A1 (fr) Virus herpetique de recombinaison avec promoteur du gene gb
Willemse et al. Recombinant feline herpesvirus vaccine
Keil Vector vaccines of bovine herpesvirus I
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.